Nexus - 1202 - New Times Magazine-pages

Page Content (OCR)

THE TRUTH BEHIND THE VACCINE COVER-UP THE TRUTH BEHIND THE COVER-UP VACCINE Medical experts who looked into Vaccine Safety Datalink research at a 2000 conference have kept quiet about the neurological damage caused by vaccines containing mercury, aluminium and other toxic adjuvants. Part 2 of 2 t the end of the conference ["Scientific Review of Vaccine Safety Datalink Information", June 7-8, 2000] a poll was taken, asking two questions: Do you think there is sufficient data to make a causal connection between the use of thimerosal-containing vaccines and neurodevelopmental delays? Do you think further study is called for, based on this study? First, let us see some of the comments on the question of doing further studies. Dr Paul Stehr-Green, Associate Professor of Epidemiology at the University of Washington's School of Public Health and Community Medicine, who voted yes, gives this as his rea- son (page 180): "The implications are so profound, these should be examined further." Meanwhile, Dr Brent interjects his concern that the lawyers will get hold of this informa- tion and begin filing lawsuits. He says (page 191): "They want business and this could potentially be a lot of business." Dr Loren Koller, pathologist and immunotoxicologist at the College of Veterinary Medicine, Oregon State University, is to be congratulated in that he recognises that more is involved in the vaccine's effects than just ethylmercury (page 192). He mentions alu- minium and even the viral agents used as being other possibilities. This is especially important in the face of Dr R. K. Gherardi's identification of macrophagic myofasciitis, a condition causing profound weakness and multiple neurological syndromes, one of which closely resembles multiple sclerosis. Both human studies and animal studies have shown a strong causal relationship to the aluminium hydroxide or aluminium phosphate used as a vaccine adjuvant. More than 200 cases have been identified in European countries, and in the United States the syndrome has been described as an "emerging condition". Here are some of the neurological problems seen with the use of aluminium hydroxide and aluminium phosphate in vaccines. In two children aged three and five, doctors at the All Children's Hospital in St Petersburg, Florida, described chronic intestinal pseudo- obstruction, urinary retention and other findings indicative of a generalised loss of auto- nomic nervous system function (diffuse dysautonomia). The three-year-old had develop- mental delay and hypotonia (loss of muscle tone). A biopsy of the children's vaccine injection site disclosed elevated aluminium levels. In a study of some 92 patients suffering from this emerging syndrome, eight developed a full-blown demyelinating CNS disorder (multiple sclerosis) (Authier F.J., Cherin P. et al., "Central nervous system disease in patients with macrophagic myofasciitis", Brain 2001; 124:974-983). This included sensory and motor symptoms, visual loss, bladder dysfunction, cerebellar signs (loss of balance and coordination) and cognitive (thinking) and behavioural disorders. Dr Gherardi, the French physician who first described the condition in 1998, has col- lected over 200 proven cases; in one third of these, the patients developed an autoimmune disease such as multiple sclerosis. Of critical importance is his finding that, even in the absence of obvious autoimmune disease, there is evidence of chronic immune stimulation caused by the injected aluminium—known to be a very powerful immune adjuvant. The reason this is so important is that there is overwhelming evidence that chronic immune activation in the brain (activation of microglial cells in the brain) is a major cause of damage in numerous degenerative brain disorders, from multiple sclerosis to the classic neurodegenerative diseases (Alzheimer's disease, Parkinson's and ALS). In fact, I have presented evidence that chronic immune activation of CNS microglia is a major cause of autism, attention deficit disorder (ADD) and Gulf War syndrome. by Russell Blaylock, MD © 2004 Website: http://www.russellblaylockmd.com by Russell Blaylock, MD © 2004 NEXUS + 19 CONCLUSIONS BY THE STUDY GROUP FEBRUARY — MARCH 2005 www.nexusmagazine.com